4//SEC Filing
BURRILL & CO LLC 4
Accession 0001181431-11-011420
CIK 0001036968other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 1:44 PM ET
Size
24.1 KB
Accession
0001181431-11-011420
Insider Transaction Report
Form 4
diaDexus, Inc.DDXS
Transactions
- Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total
Transactions
- Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total - Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total
Burrill & CO (Life Sciences GP), LLC
10% Owner
Transactions
- Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total - Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total
BURRILL & CO LLC
10% Owner
Transactions
- Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total - Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total - Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total
Burrill & CO (Indiana GP), LLC
10% Owner
Transactions
- Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total
BURRILL STEVEN
10% Owner
Transactions
- Purchase
Common Stock
2011-01-21$0.40/sh+55,500$22,200→ 5,355,387 total - Purchase
Common Stock
2011-01-28$0.38/sh+13,000$4,940→ 5,468,387 total - Purchase
Common Stock
2011-02-01$0.39/sh+15,300$5,967→ 5,483,687 total - Purchase
Common Stock
2011-02-02$0.40/sh+15,000$6,000→ 5,498,687 total - Purchase
Common Stock
2011-02-03$0.40/sh+15,287$6,115→ 5,513,974 total - Purchase
Common Stock
2011-01-24$0.40/sh+100,000$40,000→ 5,455,387 total - Purchase
Common Stock
2011-02-07$0.40/sh+5,000$2,000→ 5,518,974 total
Footnotes (9)
- [F1]The securities ("Securities") constitute the common stock of diaDexus, Inc. (the "Company") directly held by Burrill Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BLSCF"), and by Burrill Indiana Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BILSCF") in the amounts set forth in footnotes 3 through 9. BLSCF and BILSCF operate together as if they are a single fund. All Securities listed in this Form 4 also represent shares indirectly held by BLSGP, BIGP, Burrill and BLLC, as each are defined below.
- [F2]Burrill & Company (Life Sciences GP), LLC ("BLSGP") and Burrill & Company (Indiana GP), LLC ("BIGP") are the general partners of BLSCF and BILSCF, respectively. G. Steven Burrill ("Burrill") controls Burrill & Company LLC ("BCLLC"), which controls BLSGP and BIGP; thus Burrill ultimately holds the power to vote and dispose of the equity interests of both BLSGP and BIGP. BLSCF, BILSCF, BLSGP, BIGP, BCLLC, and Burrill (the "Reporting Persons") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Each Reporting Person disclaims beneficial ownership of the Securities, except to the extent of its pecuniary interest therein.
- [F3]Represent 53,087 shares directly held by BLSCF, 2,413 shares directly held by BILSCF, and 55,500 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F4]Represent 95,652 shares directly held by BLSCF, 4,348 shares directly held by BILSCF, and 100,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F5]Represent 12,435 shares directly held by BLSCF, 565 shares directly held by BILSCF, and 13,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F6]Represent 14,635 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,300 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F7]Represent 14,348 shares directly held by BLSCF, 652 shares directly held by BILSCF, and 15,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F8]Represent 14,622 shares directly held by BLSCF, 665 shares directly held by BILSCF, and 15,287 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
- [F9]Represent 4,783 shares directly held by BLSCF, 217 shares directly held by BILSCF, and 5,000 shares indirectly held by BLSGP, BIGP, Burrill and BLLC.
Documents
Issuer
diaDexus, Inc.
CIK 0001036968
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001134270
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 1:44 PM ET
- Size
- 24.1 KB